-
Orcosa Appoints Andrew C. von Eschenbach, M.D. and Former Commissioner of the FDA, as Senior Advisor
14 Jul 2022 13:26 GMT
… announced the appointment of Dr. Andrew C. von Eschenbach, former Commissioner of the U …
-
Bausch + Lomb Announces 2024 Annual Meeting of Shareholder Results
29 May 2024 20:52 GMT
…
81,674
3,089,749
Andrew C. von Eschenbach, M.D.
344,353,602 …
-
Florida gets FDA approval for Canadian drug importation plan
05 Jan 2024 16:14 GMT
… — Margaret Hamburg, Mark McClellan and Andrew Von Eschenbach — told Congress such an effort …
-
TriSalus Life Sciences Completes Merger with MedTech Acquisition Corporation
10 Aug 2023 20:38 GMT
… Hicks, Dr. Anil Singhal, Dr. Andrew C. von Eschenbach, Kelly Martin, David J. Matlin …
-
Bausch + Lomb Announces 2023 Annual Meeting of Shareholder Results
25 Apr 2023 11:15 GMT
… ,817,336
2,315,925
Andrew C. von Eschenbach, M.D.
343,985,915 …
-
Bausch + Lomb Announces 2023 Annual Meeting of Shareholder Results
25 Apr 2023 11:25 GMT
… ,817,336
2,315,925
Andrew C. von Eschenbach, M.D.
343,985,915 …
-
Bausch + Lomb Announces 2023 Annual Meeting of Shareholder Results
25 Apr 2023 11:06 GMT
… ,817,336
2,315,925
Andrew C. von Eschenbach, M.D. 343,985,915 …
-
Bringing Cancer Education to American Indian Communities
07 Apr 2023 05:55 GMT
… ., former National Cancer Institute Director Andrew C. von Eschenbach, MD, and former U.S …
-
Improving cancer awareness among the rural American Indian communities
07 Apr 2023 02:10 GMT
… ., former National Cancer Institute Director Andrew C. von Eschenbach, MD, and former U.S …